118 related articles for article (PubMed ID: 17435619)
1. Case files from Stanford University Medical Center: ten years of HAART: a long wait for full HIV suppression.
Shulman N; Shafer RW
MedGenMed; 2007 Jan; 9(1):10. PubMed ID: 17435619
[No Abstract] [Full Text] [Related]
2. [Antiretroviral therapy in 2004].
Jablonowski H
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
[TBL] [Abstract][Full Text] [Related]
3. HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.
Jones R; Gazzard B
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):303-12. PubMed ID: 16597210
[TBL] [Abstract][Full Text] [Related]
4. Managing HIV/AIDS patients.
Paul SM; Sensakovic J; Podhurst LS; Morgan DH; Triano-Davis W
N J Med; 1998 May; 95(5):55-60. PubMed ID: 16013158
[No Abstract] [Full Text] [Related]
5. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
6. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.
Hastings IM; Lalloo DG; Khoo SH
AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825
[No Abstract] [Full Text] [Related]
7. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
Gazzard BG; Anderson J; Babiker A; Boffito M; Brook G; Brough G; Churchill D; Cromarty B; Das S; Fisher M; Freedman A; Geretti AM; Johnson M; Khoo S; Leen C; Nair D; Peters B; Phillips A; Pillay D; Pozniak A; Walsh J; Wilkins E; Williams I; Williams M; Youle M;
HIV Med; 2008 Oct; 9(8):563-608. PubMed ID: 18826546
[No Abstract] [Full Text] [Related]
8. Regression of a cervical spinal mass following highly active antiretroviral therapy (HAART) in child with advanced human immunodeficiency virus (HIV) disease.
Leng LK; Pancharoen C; Bunupuradah T; Thisyakorn U; Trinavarat P; Sosothikul D; Ananworanich J
J Med Assoc Thai; 2007 Sep; 90(9):1937-42. PubMed ID: 17957942
[TBL] [Abstract][Full Text] [Related]
9. German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004).
Salzberger B; Marcus U; Vielhaber B; Arasteh K; Gölz J; Brockmeyer NH; Rockstroh J
Eur J Med Res; 2004 Nov; 9(11):491-504. PubMed ID: 15649858
[TBL] [Abstract][Full Text] [Related]
10. HAART improves quality of life: should we care about the quality of spermatozoa?
Vernazza P
AIDS; 2008 Mar; 22(5):647-8. PubMed ID: 18317007
[No Abstract] [Full Text] [Related]
11. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico.
Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B
AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946
[TBL] [Abstract][Full Text] [Related]
12. Impact of transmission of drug-resistant HIV on the course of infection and the treatment success. Data from the German HIV-1 Seroconverter Study.
Poggensee G; Kücherer C; Werning J; Somogyi S; Bieniek B; Dupke S; Jessen H; Hamouda O;
HIV Med; 2007 Nov; 8(8):511-9. PubMed ID: 17944684
[TBL] [Abstract][Full Text] [Related]
13. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract.
Pasquier CJ; Moinard N; Sauné K; Souyris C; Lavit M; Daudin M; Izopet J; Bujan L
AIDS; 2008 Sep; 22(14):1894-6. PubMed ID: 18753873
[No Abstract] [Full Text] [Related]
14. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
Fairall LR; Bachmann MO; Louwagie GM; van Vuuren C; Chikobvu P; Steyn D; Staniland GH; Timmerman V; Msimanga M; Seebregts CJ; Boulle A; Nhiwatiwa R; Bateman ED; Zwarenstein MF; Chapman RD
Arch Intern Med; 2008 Jan; 168(1):86-93. PubMed ID: 18195200
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
[TBL] [Abstract][Full Text] [Related]
17. Combination antiretroviral therapy failure and HIV super-infection.
Bezemer D; van Sighem A; de Wolf F; Cornelissen M; van der Kuyl AC; Jurriaans S; van der Hoek L; Prins M; Coutinho RA; Lukashov VV
AIDS; 2008 Jan; 22(2):309-11. PubMed ID: 18097235
[TBL] [Abstract][Full Text] [Related]
18. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.
Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC
J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088
[TBL] [Abstract][Full Text] [Related]
19. [Antiretroviral therapies: strategic perspectives for the future].
Reynes J
Med Trop (Mars); 2007 Aug; 67(4):367. PubMed ID: 17926796
[No Abstract] [Full Text] [Related]
20. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
;
Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
